chr11-6921387-C-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001004684.1(OR2D3):c.386C>T(p.Ala129Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000576 in 1,613,826 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001004684.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OR2D3 | NM_001004684.1 | c.386C>T | p.Ala129Val | missense_variant | 1/1 | ENST00000317834.5 | NP_001004684.1 | |
LOC107984019 | XR_001748111.2 | n.931+3111G>A | intron_variant | |||||
LOC107984019 | XR_001748112.3 | n.1466+3111G>A | intron_variant | |||||
LOC107984019 | XR_007062575.1 | n.980+3111G>A | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OR2D3 | ENST00000317834.5 | c.386C>T | p.Ala129Val | missense_variant | 1/1 | 6 | NM_001004684.1 | ENSP00000320560.3 | ||
ENSG00000283415 | ENST00000637205.2 | n.605+3111G>A | intron_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.000256 AC: 39AN: 152078Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000996 AC: 25AN: 250978Hom.: 0 AF XY: 0.0000590 AC XY: 8AN XY: 135624
GnomAD4 exome AF: 0.0000369 AC: 54AN: 1461630Hom.: 2 Cov.: 51 AF XY: 0.0000344 AC XY: 25AN XY: 727096
GnomAD4 genome AF: 0.000256 AC: 39AN: 152196Hom.: 0 Cov.: 32 AF XY: 0.000242 AC XY: 18AN XY: 74402
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 09, 2024 | The c.386C>T (p.A129V) alteration is located in exon 1 (coding exon 1) of the OR2D3 gene. This alteration results from a C to T substitution at nucleotide position 386, causing the alanine (A) at amino acid position 129 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at